The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation

NCT02737735 Phase 1 UNKNOWN

To study the effect on decreasing chemotherapeutic toxicity and increasing anti-tumor treatment of Chinese Herbs based on syndrome differentiation

Details

Lead sponsor	First Affiliated Hospital, Sun Yat-Sen University
Phase	Phase 1
Status	UNKNOWN
Enrolment	200
Start date	2016-03
Completion	2020-01

Conditions

• Carcinoma, Non-Small-Cell Lung

Interventions

• standard chemotherapy medicine combined with Chinese herbs
• standard chemotherapy medicine

Primary outcomes

• Overall survival rate — 36months
• progression-free survival rate — 36months

Countries

China